brand logo
  1. Clinicians should be aware that intravascular injection of dermal fillers around the nose, glabella, or nasolabial fold can cause periocular embolism, leading to blindness. Refer patients with symptoms of vision loss and ocular pain after such injection procedures to an ophthalmology subspecialist for emergent consultation.

  2. If a patient presents with severe pain or sensation of pressure after undergoing blepharoplasty, perform an emergent evaluation to rule out retrobulbar hemorrhage. If retrobulbar hemorrhage or other vision-threatening complication is present, refer the patient to an ophthalmology subspecialist immediately.

  3. For patients with breast implants, recommend regular breast cancer screening with mammography per standard recommendations.

  4. Refer any patient who has undergone breast augmentation who presents with a breast lump to a breast unit for evaluation.


  1. Strength of Evidence: SORT B

    Sources: Plast Reconstr Surg, Plast Reconstr Surg, references 43 and 44

  2. Websites:;

  3. Strength of Evidence: SORT B

    Source: Oculofacial, Orbital, and Lacrimal Surgery, reference 59

  4. Strength of Evidence: SORT B

    Source: American Cancer Society, reference 140

  5. Website:

  6. Strength of Evidence: SORT B

    Source: Women’s Health (Lond), reference 138

  7. Website:

Already a subscriber?  Log In


From $335
  • Immediate, unlimited access to all FP Essentials content
  • 60 CME credits/year
  • AAFP app access
  • Print delivery available

Edition Access

  • Immediate, unlimited access to this edition's content
  • 5 CME credits
  • AAFP app access
  • Print delivery available
Interested in AAFP membership? Learn more  Learn More

Continue Reading

Copyright © 2020 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.